The patient has failed all other available agents and has intractable epilepsy due to Dravet
Syndrome. Stiripentol is highly efficacious in Dravet Syndrome. The overall goals of therapy
with Stiripentol are primarily to significantly reduce the frequency and severity of
seizures.